References
- Beck A. J., Beck R. W. Screening depressed patients in family practices: A rapid technique. Postgrad. Med. 1972; 52: 1181–1185
- Blachly P. H. Naloxone for diagnosis in methadone programs. J. Am. Med. Assoc. 1973; 224: 334–335
- Blumberg H., Dayton H. B., George M., Rapaport D. N. N-Allynoroxy-morphone: A potent narcotic antagonist. Fed. Proc. 1961; 20: 311
- Derogatis L. R., Lipman R. S., Cori L. SCL-90: An outpatient psychiatric rating scale-preliminary report. Psychopharmacol. Bull. 1973; 9: 13–28
- Jaffe J. H. Drug addiction and drug abuse. The Pharmacological Basis of Therapeutics, A. G. Gilman, L. S. Goodman, T. W. Rail, R. Murad. Macmillan, New York 1985; 532–581
- Judson B. A., Himmelberger D. U., Goldstein A. The naloxone test for opiate dependence. Clin. Pharmacol. Ther. 1980; 27: 492–501
- Khantzian E. The self medication hypothesis of addictive disorders: Focus on heroin and cocaine dependence. Am. J. Psychiatry 1985; 142: 1259–1264
- Khantzian E. J., Mack J. E., Schatzberg A. F. Heroin use as an attempt to cope: Clinical observations. Am. J. Psychiatry 1974; 131: 160–164
- Khantzian E. J., Treece C. DSM-III psychiatric diagnosis of narcotic addicts: Recent findings. Arch. Gen. Psychiatry 1985; 42: 1067–1071
- McLellan A. T., Luborsky L., Woody G. E., O'Brien C. P., Druley K. A. Predicting response to alcohol and drug abuse treatments: Role of psychiatric severity. Arch. Gen. Psychiatry 1983; 40: 620–625
- O'Brien C. P. Experimental analysis of conditioning factors in human narcotic addiction. Pharmacol. Rev. 1976; 27: 533–543
- O'Brien C. P., Greenstein R., Ternes J., Woody G. E. Clinical pharmacology of narcotic antagonists. Ann. N. Y. Acad. Sci. 1978; 311: 232–240
- Rounsaville B. J., Kosten T. R., Weissman M. M., Kleber H. D. Evaluating and Treating Depressive Disorders in Opiate Addicts (NIDA Research Monograph). National Institute on Drug Abuse, Rockville, Maryland 1985
- Rounsaville B. J., Kosten T. R., Weissman M. M., Kleber H. D. Prognostic significance of psychopathology in treated opiate addicts: A 2.5 year follow-up study. Arch. Gen. Psychiatry 1986; 43: 739–745
- Rounsaville B. J., Weissman M. M., Crits-Christoph K., Wilber C, Kleber H. D. Diagnosis and symptoms of depression in opiate addicts: Course and relationship to treatment outcome. Arch. Gen. Psychiatry 1982; 39: 151–156
- Spitzer R. L., Williams J. B., Gibbon M. The Structured Clinical Interview for DSM-UI-R-Outpatient Version (SCID-OP, 1987). Biometrics Research Department, New York State Psychiatric Institute, New York, New York, 722 West 168th Street 10032
- Wang R. I. H., Wiesen R. L., Lamid S., Roh B. L. Rating the presence and severity of opiate dependence. Clin. Pharmacol. Ther. 1974; 16: 653–658
- Way E. L., Loh H. H. Responsivity to naloxone during morphine dependence. Ann. N. Y. Acad. Sci. 1976; 281: 252–261
- Wiesen R. L., Rich C. R., Wang R. I. H., Stockdale S. L. The safety and value of naloxone as a therapeutic aid. Drug Alcohol Depend 1977; 2: 123–130
- Woody G. E., McLellan A. T., Luborsky L., O'Brien C. P., Blaine J., Fox S., Herman I., Beck A. T. Severity of psychiatric symptoms as a predictor of benefits from psychotherapy: The Veterans Administration-Penn study. Am. J. Psychiatry 1984; 141: 1172–1177
- Wurmser L. Psychoanalytic consideration of the etiology of compulsive drug use. J. Am. Psychoanal. Assoc. 1974; 22: 820–843
- Zilm D. H., Sellers E. M. The quantitative assessment of physical dependence on opiates. Drug Alcohol Depend 1978; 3: 419–428